445 related articles for article (PubMed ID: 7622580)
21. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
Yue J; Sun B; Liu G; Mulder KM
J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
[TBL] [Abstract][Full Text] [Related]
22. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
[TBL] [Abstract][Full Text] [Related]
23. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
24. The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.
Fawthrop FW; Oyajobi BO; Bunning RA; Russell RG
J Bone Miner Res; 1992 Dec; 7(12):1363-71. PubMed ID: 1481722
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activation by airway smooth muscle is regulated by type I collagen.
Schuliga M; Harris T; Stewart AG
Am J Respir Cell Mol Biol; 2011 Jun; 44(6):831-9. PubMed ID: 20693403
[TBL] [Abstract][Full Text] [Related]
26. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
[TBL] [Abstract][Full Text] [Related]
27. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
Yoshizawa M; Miyazaki H; Kojima S
J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
[TBL] [Abstract][Full Text] [Related]
28. Plasmin-catalyzed proteolysis in colorectal neoplasia.
Delbaldo C; Cunningham M; Vassalli JD; Sappino AP
Cancer Res; 1995 Oct; 55(20):4688-95. PubMed ID: 7553650
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225
[TBL] [Abstract][Full Text] [Related]
30. Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.
Wagner SN; Atkinson MJ; Thanner S; Wagner C; Schmitt M; Wilhelm O; Rotter M; Höfler H
Am J Pathol; 1995 Jul; 147(1):183-92. PubMed ID: 7604879
[TBL] [Abstract][Full Text] [Related]
31. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
[TBL] [Abstract][Full Text] [Related]
32. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
[TBL] [Abstract][Full Text] [Related]
33. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line.
Boyd D
Cancer Res; 1989 May; 49(9):2427-32. PubMed ID: 2539903
[TBL] [Abstract][Full Text] [Related]
34. Binding and activation of plasminogen on the surface of osteosarcoma cells.
Campbell PG; Wines K; Yanosick TB; Novak JF
J Cell Physiol; 1994 Apr; 159(1):1-10. PubMed ID: 7511144
[TBL] [Abstract][Full Text] [Related]
35. Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line.
Boyd D; Brattain M
Cancer Res; 1989 Apr; 49(8):1948-53. PubMed ID: 2539250
[TBL] [Abstract][Full Text] [Related]
36. Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines.
Boyd D; Florent G; Kim P; Brattain M
Cancer Res; 1988 Jun; 48(11):3112-6. PubMed ID: 2835152
[TBL] [Abstract][Full Text] [Related]
37. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells.
Perkins RC; Broaddus VC; Shetty S; Hamilton S; Idell S
Am J Respir Cell Mol Biol; 1999 Nov; 21(5):637-46. PubMed ID: 10536123
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor beta induces urokinase receptor expression in cultured retinal pigment epithelial cells.
Sirén V; Myöhänen H; Vaheri A; Immonen I
Ophthalmic Res; 1999; 31(3):184-91. PubMed ID: 10224501
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis.
Melnick M; Chen H; Buckley S; Warburton D; Jaskoll T
Dev Dyn; 1998 Jan; 211(1):11-25. PubMed ID: 9438420
[TBL] [Abstract][Full Text] [Related]
40. The receptor for urokinase-plasminogen activator.
Blasi F; Stoppelli MP; Cubellis MV
J Cell Biochem; 1986; 32(3):179-86. PubMed ID: 3023408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
